胃癌淋巴结转移率分期及其生存预测价值的研究现状
Research Status of Lymph Node Metastasis Rate Stage and Predictive Value of Survival in Gastric Cancer
DOI: 10.12677/ACM.2021.119606, PDF,   
作者: 满孝丽：延安大学附属医院，陕西 延安；李小宝：延安大学附属医院胃肠疝外科，陕西 延安
关键词: 胃癌；淋巴结转移率；淋巴结转移率分期；生存预测价值；Gastric Cancer； Metastatic Lymph Node Ratio； Lymph Node Metastatic Ratio Stage； Predictive Value of Survival
摘要: 淋巴结转移是影响胃癌患者预后的重要因素之一，准确判断胃癌淋巴结转移状态对评估患者预后至关重要。pN分期作为临床最常用的淋巴结分期系统，由于存在阶段性分期偏倚，在一定程度上影响患者术后辅助治疗及预后评估。为解决这一问题，国内外学者提出用淋巴结转移率来评价胃癌患者的预后，但概念的混乱和淋巴结转移率分期临界值的不一致对其在临床推广应用产生一定影响。目前，淋巴结转移率分期及其对患者生存预测的价值仍是研究的一大热点。
Abstract: Lymph node metastasis is one of the important factors affecting the prognosis of gastric cancer patients. It is very important to accurately determine the status of lymph node metastasis in gastric cancer patients. pN staging is the most commonly used lymph node staging system in clinic. Due to stage bias, it affects postoperative adjuvant therapy and prognosis assessment to some extent. In order to solve this problem, domestic and foreign scholars proposed to use lymph node metastasis rate to evaluate the prognosis of gastric cancer patients, but the confusion of concepts and the inconsistent staging threshold of lymph node metastasis rate have a certain impact on its clinical application. At present, lymph node metastasis rate and stage and its value in predicting patient survival are still a hot research area.
文章引用：满孝丽, 李小宝. 胃癌淋巴结转移率分期及其生存预测价值的研究现状[J]. 临床医学进展, 2021, 11(9): 4155-4159. https://doi.org/10.12677/ACM.2021.119606

参考文献

[1] 陈孝平, 汪建平. 第八版外科学[M]. 北京: 人民卫生出版社, 2013.
[2] 王锦姝, 王瑞康, 张鑫众, 王巍, 刘刚. 腹腔镜进展期胃癌根治术淋巴结检出数目的影响因素分析[J]. 中国普外基础与临床杂志, 2021, 28(6): 732-736.
[3] Baiocchi, G.L., Kodera, Y., Marrelli, D., et al. (2014) Follow-Up after Gastrectomy for Cancer: Results of an International Web Round Table. World Journal of Gastroenterology, 20, 11966-11971. [Google Scholar] [CrossRef] [PubMed]
[4] 张恒, 何文玢, 何军, 焦增涛, 刘红岩. 医学知识增强的肿瘤分期多任务学习模型[J/OL]. 智能系统学报, 1-10. http://kns.cnki.net/kcms/detail/23.1538.tp.20210330.1322.002.html, 2021-07-17.
[5] 饶鸿艳. 淋巴结转移率与胃癌根治术后患者预后的关系[D]: [硕士学位论文]. 福州: 福建医科大学, 2016.
[6] 胡祥, 张驰. 第15版日本《胃癌处理规约》拔萃[J]. 中国实用外科杂志, 2018, 38(5): 520-528.
[7] 刘文奇, 杜江. 胃癌切除术后淋巴结转移率与TNM分期系统对患者预后的影响比较[J]. 山西医药杂志, 2020, 49(22): 3119-3122.
[8] Siewert, J.R., Btcher, K., Stein, H.J., et al. (1998) Relevant Prognostic Factors in Gastric Cancer: Ten-Year Results of the German Gastric Cancer Study. Annals of Surgery, 228, 449-461. [Google Scholar] [CrossRef] [PubMed]
[9] 李晨, 杜晓辉, 陈凛. 胃癌淋巴结转移率分期的研究现状[J]. 解放军医学院学报, 2014, 35(6): 634-636.
[10] 耿宏智. 影响进展期胃癌淋巴结转移率和转移数量分期的病理因素[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2013.
[11] 马志坚, 王科深, 任彦先, 焦作义. 淋巴结转移率对胃癌患者的预后价值[J]. 中国普外基础与临床杂志, 2020, 27(11): 1352-1356.
[12] Sun, Z., Zhu, G.L., Lu, C., et al. (2009) The Impact of N-Ratio in Minimizing Stage Migration Phenomenon in Gastric Cancer Patients with Insufficient Number or Level of Lymph Node Retrieved: Results from a Chinese Mono-Institutional Study in 2 159 Patients. Annals of Oncology, 20, 897-905. [Google Scholar] [CrossRef] [PubMed]
[13] 吴海滨, 张华秦, 谢辉, 刘勇. 淋巴结转移率与Ⅲ期胃癌患者D2根治术后生存率和化疗获益的关系研究[J]. 中国消化内科杂志2019, 27(5): 357-360+366.
[14] 尹杰, 蔡军, 张军, 郑智, 刘钊, 张忠涛. 早期胃癌淋巴结转移相关危险因素研究[J]. 中国实用外科杂志, 2016, 36(1): 111-114+118.
[15] 朱志, 杜雨薇, 刘福囝, 高鹏, 王振宁. 淋巴结转移在胃癌预后中的评价[J]. 腹部外科, 2021, 34(3): 179-183+188.
[16] Saito, H., Fukumoto, Y., Osaki, T., et al. (2008) Prognostic Significance of the Ratio between Metastatic and Dissected Lymph Nodes (n Ratio) in Patients with Advanced Gastric Cancer. Journal of Surgical Oncology, 97, 132-135. [Google Scholar] [CrossRef] [PubMed]
[17] Kodera, Y., Yamamura, Y., Shimizu, Y., et al. (1998) Lymph Node Status Assessment for Gastric Carcinoma: Is the Number of Metastatic Lymph Nodes Really Practical as a Parameter for N Categories in the TNM Classification? Tumor Node Metastasis. Journal of Surgical Oncology, 69, 15-20. [Google Scholar] [CrossRef] 
[18] 徐大志, 詹友庆, 李威, 周志伟, 陈映波, 孙晓卫, 陈功, 关远祥, 李元方. 阳性淋巴结转移率在胃癌D2术后的临床意义[C]//中国抗癌协会、中华医学会肿瘤学分会. 第五届中国肿瘤学术大会暨第七届海峡两岸肿瘤学术会议、国际肿瘤细胞与基因治疗学会会议、第二届中日肿瘤介入治疗学术会议论文集. 2008: 611-612.
[19] 肖隆斌, 杨世斌, 许峰峰, 黎文峰, 吴文辉, 李明哲. 淋巴结转移率对胃癌根治术后患者预后的评估价值[J]. 中华胃肠外科杂志, 2013(1): 56-59.
[20] Kano, K., Yamada, T., Yamamoto, K., Komori, K., Watanabe, H., Hara, K., Shimoda, Y., Maezawa, Y., Fujikawa, H., Aoyama, T., Tamagawa, H., Yamamoto, N., Cho, H., Shiozawa, M., Yukawa, N., Yoshikawa, T., Morinaga, S., Rino, Y., Masuda, M., Ogata, T. and Oshima, T. (2020) Association between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Annals of Surgical Oncology, 27, 423. [Google Scholar] [CrossRef] [PubMed]
[21] 李良, 谢家存, 王志斌, 梁恒坡, 吴广银. 淋巴结转移率对Ⅲ期胃癌术后辅助放疗疗效的评估作用[J]. 中华放射医学与防护杂志, 2021, 41(5): 346-352.
[22] Serrato, M. and Marian, A.J. (1995) A Variant of Human Paraoxonase/Arylesterase (HUMPONA) Gene Is a Risk Factor for Coronary Artery Disease. Journal of Clinical Investigation, 96, 3005-3008. [Google Scholar] [CrossRef] 

为你推荐